KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Free Cash Flow (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Free Cash Flow for 7 consecutive years, with -$68.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 76.82% year-over-year to -$68.2 million, compared with a TTM value of -$68.4 million through Dec 2025, down 184.53%, and an annual FY2025 reading of -$66.9 million, down 182.74% over the prior year.
  • Free Cash Flow was -$68.2 million for Q4 2025 at Clover Health Investments, down from $11.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $101.4 million in Q3 2022 and bottomed at -$257.8 million in Q4 2023.
  • Average Free Cash Flow over 5 years is -$31.2 million, with a median of -$27.5 million recorded in 2024.
  • The sharpest move saw Free Cash Flow plummeted 594.55% in 2021, then soared 2598.27% in 2024.
  • Year by year, Free Cash Flow stood at -$80.4 million in 2021, then plummeted by 165.18% to -$213.2 million in 2022, then fell by 20.9% to -$257.8 million in 2023, then skyrocketed by 85.05% to -$38.5 million in 2024, then plummeted by 76.82% to -$68.2 million in 2025.
  • Business Quant data shows Free Cash Flow for CLOV at -$68.2 million in Q4 2025, $11.4 million in Q3 2025, and $4.8 million in Q2 2025.